(Q40560117)

21 September 2017

Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A280146

history and philosophy of science

19 February 2023

main subject

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

19 February 2023

author name string

W. M. Shannon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A280146

19 February 2023

language of work or name

English

0 references

publication date

1 March 1977

1 reference

21 September 2017

4 March 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=280146

full work available at URL

19 February 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1977.tb21983.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1977.tb21983.x/fullpdf

19 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Annals of the New York Academy of Sciences

19 February 2023

published in

1 reference

21 September 2017

284

1 reference

21 September 2017

472-507

1 reference

3-Deazauridine: inhibition of ribonucleic acid virus-induced cytopathogenic effects in vitro

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

RNA-directed DNA polymerase and virus-induced leukemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Antiviral agents. 1-Aralkyloxyadenosines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Inhibition of herpes simplex virus replication by phosphonoacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Phosphonoacetic Acid in the Treatment of Experimental Herpes Simplex Keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Phosphonoacetic Acid-Resistant Herpes Simplex Virus Infection in Hairless Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Inhibition of the DNA Polymerase of Rauscher Leukemia Virus by Single-Stranded Polyribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Effects of Poly(2′- O -Methyladenylic Acid) on Susceptibility and Autogenous Immunity to RNA Tumor Virus Oncogenesis In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Atmospheric Ice Nuclei from Decomposing Vegetation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1977.TB21983.X

Viral RNA subunits in cells transformed by RNA tumor viruses

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Biochemical suppression of tumor virus activity

19 February 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Antiviral Activity of 9- -D-Arabinofuranosyladenine (ara-A) Against Gross Murine Leukemia Virus in Vitro

19 February 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine.

19 February 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Inhibition of gross leukemia virus-induced plaque formation in XC cells by 3-deazauridine

19 February 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Inhibition of gross murine leukemia virus replication by rifamycin SV and certain of its derivatives in vitro

19 February 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Plaque assay techniques for murine leukemia viruses

19 February 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

19 February 2023

13

23

762

Chirigos M. A.

1963

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Biochemistry and biological effects of the pyrazofurins (pyrazomycins): initial clinical trial

19 February 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice

19 February 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Studies on the biochemical basis for the antiviral activities of some nucleoside analogs

19 February 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

19 February 2023

37

35

2160

Muller W. E. G.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

19 February 2023

38

35

415

Plunkett W.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines

19 February 2023

42

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

19 February 2023

48

35

1547

Plunkett W.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine

19 February 2023

50

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Therapeutic activity of narcissus alkaloids on Rauscher leukemia: antiviral effect in vitro and rational drug combination in vivo

19 February 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Inhibition of DNA polymerase from herpes simplex virus-infected wi-38 cells by phosphonoacetic Acid.

19 February 2023

61

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

DNA polymerases from RNA tumor viruses and human cells: inhibition by polyuridylic acid.

19 February 2023

66

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Effects of polyadenylic acids on functions of murine RNA tumor viruses

19 February 2023

67

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Leukaemic transformation of engrafted human marrow cells in vivo

19 February 2023

73

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

19 February 2023

74

33

3061

Rowe W. P.

1973

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

Metabolic inhibitors and viral lymphomagenesis in thymic grafts

19 February 2023

76

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1977.TB21983.X

19 February 2023

Identifiers

1 reference

21 September 2017

1 reference